Why 340B conflicts won't end with new and coming rules

07/23/2013 | PharmExec.com

Conflict over the 340B drug discounts will go on even as new rules bring more clarity to the program, Jill Wechsler writes. The Health Resources and Services Administration issued a final rule on the coverage of orphan drugs, and the Office of Pharmacy Affairs could issue more sweeping rules next year.

View Full Article in: